JAMA Oncology Author Interviews podcast

Atezolizumab in Combination With Carboplatin in Metastatic TNBC

0:00
18:18
Reculer de 15 secondes
Avancer de 15 secondes

Interview with Jennifer A. Pietenpol, PhD, Brian D. Lehmann, PhD, and Vandana G. Abramson, MD, authors of Atezolizumab in Combination With Carboplatin and Survival Outcomes in Patients With Metastatic Triple-Negative Breast Cancer: The TBCRC 043 Phase 2 Randomized Clinical Trial. Hosted by Mary L. (Nora) Disis, MD.

Related Content:

D'autres épisodes de "JAMA Oncology Author Interviews"